Unleashing automated white matter lesion segmentation: Advancements in MS assessment. Evolving imaging techniques, revolutionizing diagnosis &...
Boston, MA, March 29, 2023— QMENTA, Inc. announced today that John E. Kelly III, PhD has been appointed to the company's Board of Advisors. Dr. Kelly...
It is difficult to diagnose Parkinson’s disease, and the only way to confirm diagnosis is postmortem. The new imaging AI tools could be the answer.
Prof. Russ Hornbeck shares insights on Alzheimer's research and imaging technology through his experience in medical imaging, discussing the DIAN...
For centuries, MS was recognized as a condition characterized by episodic and progressive neurological deterioration, classified as ‘paraplegia’
The imaging clinical trials industry is growing at a fast pace. To help you keep up, we have investigated the top trends to look for in 2023!
At RSNA 2022, our team discussed the latest advances in imaging trials software, including state-of-the-art digital biomarkers algorithms.
Neurotech is evolving faster than ever, and staying on top of trends is a must for researchers. Discover the major neuroscience trends for 2023.
In order to assure that QMENTA is a reliable trusted partner for managing your medical data, we follow the highest security standards.